Abstract
Retina is particularly susceptible to ischaemic damage following exposure to anoxia or hypoglycaemia. In animal models the neuronal damage following ischaemia resembles that caused by exposure to glutamate or other excitotoxic agents which act on excitatory amino acid receptors. There are a number of pharmacological approaches designed to limit neuronal damage following ischaemia. These include free radical scavenging agents, calcium channel blockers, kappa opiate agonists and excitatory amino acid antagonists. Recent studies with antagonists acting at both NMDA and non-NMDA receptors for glutamate show that such compounds can protect against ischaemic damage, and are effective even when administered several hours after the ischaemic insult.
Similar content being viewed by others
Article PDF
References
Krieglstein J (ed): ‘Pharmacology of Cerebral Ischaemia 1988’, CRC Press, Boca Raton, Florida, 1989.
Krieglstein J (ed): ‘Pharmacology of Cerebral Ischaemia 1990’, CRC Press, Boca Raton, Florida (in press).
Fieschi C and Lenzi GL (eds.): Proceedings of Brain 89. J Cerebral Blood Flow Metab 1989, 9: Suppl 1.
Lucas DR and Newhouse JP : The toxic effects of L-glutamate on the inner layers of the retina. Arch Ophthalmol 1957, 58: 193–201.
Olney JW : Brain lesions obesity and other disturbances in mice treated with monosodium glutamate. Science 1969, 164: 719–21.
Olney JW : The toxic effects of glutamate and related compounds in the retina and the brain. Retina 1982, 2: 341–59.
Watkins JC and Evans RH : Excitatory amino acid transmitters. Ann Rev Pharmacol Toxicol 1981,; 21: 165–204.
Schwarcz R and Meldrum B : Excitatory amino acid antagonists provide a therapeutic approach to neurological disorders. Lancet 1985, ii, 140–3.
Rothman S : Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neuroscience 1984, 4: 1884–91.
Cotman CW and Iversen LL : Excitatory amino acids in the brain—focus on NMD A receptors. Trends in Neurosciences 1987, 10: 263–301.
Foster AC and Fagg GE : Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors. Brain Res Rev 1984, 7: 103–64.
Watkins JC and Collingridge GL (eds): ‘The NMDA Receptor’, IRL Press, Oxford, 1989.
Honore T, Davies SD, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE : Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science 1988, 241: 701–3.
Olney J, Price M, Salles S, Labruyere J, Frierdich G : MK-801 powerfully protects against N-methyl aspartate neurotoxicity. Euro J Pharmacol 1987, 141: 357–61.
Choi DW, Koh JY, Peters S : Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosc 1988, 8: 185–96.
Zeevalk GD and Nicklas WJ : Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina. Pharmacol Exp Therapeut 1990, 253: 1285–92.
Price MT, Honore T, Mueller MEM, Labruyere J, Silverman E, Olney J, CNQX potently and selectively blocks kainate excitotoxicity in the chick embryo retina. Society for Neuroscience (Abstracts) 1988, 14: 418.
David P, Lusky M, Teichberg VI . Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp Eye Res 1988, 46: 657–62.
Levy DI and Lipton SA : Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology 1990, 40: 852–55.
Meldrum BS, Chapman AG, Patel S, Swan J : Competitive NMDA antagonists as drugs. In ‘The NMDA Receptor’ eds. J.C. Watkins & G. L. Collingridge, pp 207–216, IRL Press, Oxford, 1989.
Iversen LL, Woodruff GN, Kemp JA, Foster AC, McKernan R, Gill R, Wong EHF : Non-competitive NMDA antagonists as drugs, idid, pp 217–226.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iversen, L. Pharmacological approaches to the treatment of ischaemic neuronal damage. Eye 5, 193–197 (1991). https://doi.org/10.1038/eye.1991.34
Issue Date:
DOI: https://doi.org/10.1038/eye.1991.34